posted on 2019-04-04, 08:13authored byGS Gulsin, DJ Swarbrick, WH Hunt, E Levelt, MPM Graham-Brown, KS Parke, JV Wormleighton, FY Lai, T Yates, EG Wilmot, DR Webb, MJ Davies, GP McCann
Individuals with type 2 diabetes have a three- to fivefold increased risk of developing heart failure. Diabetic cardiomyopathy is typified by left ventricular (LV) concentric remodeling, which is a recognized predictor of adverse cardiovascular events. Although the mechanisms underlying LV remodeling in type 2 diabetes are unclear, progressive aortic stiffening may be a key determinant. The aim of this study was to assess the relationship between aortic stiffness and LV geometry in younger adults with type 2 diabetes, using multiparametric cardiovascular MRI. We prospectively recruited 80 adults (aged 18-65 years) with type 2 diabetes and no cardiovascular disease and 20 age- and sex-matched healthy control subjects. All subjects underwent comprehensive bio-anthropometric assessment and cardiac MRI, including measurement of aortic stiffness by aortic distensibility (AD). Type 2 diabetes was associated with increased LV mass, concentric LV remodeling, and lower AD compared with control subjects. On multivariable linear regression, AD was independently associated with concentric LV remodeling in type 2 diabetes. Aortic stiffness may therefore be a potential therapeutic target to prevent the development of heart failure in type 2 diabetes.
Funding
This study is part of the research portfolio supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (Research Trainees Coordinating Centre grant CDF-2014-07-045). G.P.M. is supported by an NIHR career development fellowship. Funding contributions were also made by Novo Nordisk and the Medical Research Council Interdisciplinary Bridging Award.
History
Citation
Diabetes, 2018, 67 (7), pp. 1395-1400
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular Sciences